Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biovie Inc. (BIVI)
:BIVI
Holding BIVI?
Track your performance easily
BIVI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.04 - $33.10
Previous CloseN/A
Volume1.62M
Average Volume (3M)1.29M
Market Cap
$41.15M
Enterprise Value$1.75M
Total Cash (Recent Filing)$5.14K
Total Debt (Recent Filing)$575.92K
Price to Earnings (P/E)―
Beta1.52
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.70
Shares Outstanding18,451,584
10 Day Avg. Volume1,301,559
30 Day Avg. Volume1,287,111
Standard Deviation0.45
R-Squared0.01
Alpha0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-2.80
P/FCF Ratio0.00
Enterprise Value/Market Cap0.04
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-0.07
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BioVie News
PremiumCompany Announcements
BioVie Raises $3.24 Million in Direct Offering
PremiumCompany Announcements
BioVie Raises Capital Through Direct Stock Offering
PremiumCompany Announcements
BioVie Raises $6 Million in Strategic FundingOwnership Overview
9.37% Insiders
0.93% Mutual Funds
0.22% Other Institutional Investors
89.00% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
BIVI FAQ
What was Biovie Inc.’s price range in the past 12 months?
Biovie Inc. lowest stock price was $1.04 and its highest was $33.10 in the past 12 months.
What is Biovie Inc.’s market cap?
Biovie Inc.’s market cap is $41.15M.
When is Biovie Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Biovie Inc.’s earnings last quarter?
Biovie Inc. released its earnings results on Feb 14, 2024. The company reported -$0.22 earnings per share for the quarter, beating the consensus estimate of -$0.275 by $0.055.
Is Biovie Inc. overvalued?
According to Wall Street analysts Biovie Inc.’s price is currently Overvalued.
Does Biovie Inc. pay dividends?
Biovie Inc. does not currently pay dividends.
What is Biovie Inc.’s EPS estimate?
Biovie Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biovie Inc. have?
Biovie Inc. has 18,451,584 shares outstanding.
What happened to Biovie Inc.’s price movement after its last earnings report?
Biovie Inc. reported an EPS of -$0.22 in its last earnings report, beating expectations of -$0.275. Following the earnings report the stock price went down -0.823%.
Which hedge fund is a major shareholder of Biovie Inc.?
Among the largest hedge funds holding Biovie Inc.’s share is Sheaff Brock Investment Advisors LLC. It holds Biovie Inc.’s shares valued at 0.
---
BioVie Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 5.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 0.6%
Last 30 Days ▲ 5.0%
Last 30 Days ▲ 5.0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-82.30%
12-Months-Change
Fundamentals
Return on Equity
-236.52%
Trailing 12-Months
Asset Growth
-10.62%
Trailing 12-Months
Company Description
Biovie Inc.
BioVie, Inc. is a development stage biopharmaceutical company, which discovers, develops, and commercializes drug therapies for liver disease. It focuses on BIV201 which treats ascites due to chronic liver cirrhosis. The company was founded on April 10, 2013 and is headquartered in Santa Monica, CA.
---
BIVI Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Annovis Bio
―
Anavex Life Sciences
―
Cassava Sciences
―
Inmune Bio
―
Athira Pharma
―
Cyclo Therapeutics
―
Best Analysts Covering BIVI
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-49.50%
initiated a buy rating 7 months ago
Copying Ashok Kumar's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -49.50% per trade.
---